Navigation Links
Leslie Zacks Joins Arbor Pharmaceuticals as General Counsel and Chief Compliance Officer
Date:2/21/2012

ATLANTA, Feb. 21, 2012 /PRNewswire/ -- Arbor Pharmaceuticals, a specialty pharmaceutical company based in Atlanta, GA, announced today that Leslie Zacks has joined the company as General Counsel and Chief Compliance Officer.  Mr. Zacks has a distinguished legal career and most recently held positions of increasing responsibility at Shionogi Pharma, Inc. (previously Sciele Pharma).  While at Shionogi, Leslie built the company's legal department and served on the company's executive leadership team where he was responsible for all legal, IP and compliance functions.

Mr. Zacks has been a practicing attorney in Atlanta, Georgia since 1994.  He was the Executive Vice President, General Counsel and Chief Compliance Officer at Shionogi Pharma, Inc. from 2004-2010.  From 2002 to 2004, Mr. Zacks worked at Hunton & Williams, LLP where he was a partner in the Intellectual Property Litigation department.  Mr. Zacks is a registered patent attorney who has held associate positions at Powell, Goldstein, Frazer & Murphy, LLP (now Bryan Cave, LLP) and at Carlock, Copeland and Stair, LLP.  Mr. Zacks holds a J.D. and a B.A. in English from the University of Florida.

Ed Schutter, President and CEO of Arbor, commented, "We are pleased that Leslie has joined Arbor in this significant role for the company.  Leslie has deep experience in patent law, mergers and acquisitions, compliance, and in many other key areas critical to Arbor as we continue our significant growth."

Mr. Zacks added, "I am pleased to be joining Arbor at this important point in the company's growth.  The company is well positioned to execute on its plan, and I look forward to building on Arbor's success in my new role."

About Arbor Pharmaceuticals, Inc.

Arbor Pharmaceuticals, headquartered in Atlanta, Georgia, is a specialty pharmaceutical company currently focused on the cardiovascular and pediatric markets. The company intends to become a leading specialty pharmaceutical company by actively licensing, developing and commercializing late-stage products for specialty focused conditions. Arbor currently markets multiple NDA and ANDA approved products with several more in development.

For more information regarding Arbor Pharmaceuticals or any of its products, visit www.arborpharma.com or send email inquiries to info@arborpharma.com.  


'/>"/>
SOURCE Arbor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors
2. Zacks Rates CardioGenics Outperform With Six-Month Target of $1.22
3. Zacks Investment Research Initiates Coverage on Viral Genetics
4. Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals
5. The Zacks Analyst Blog Highlights: Pfizer, Bristol - Myers Squibb, Eli Lilly, Forest Laboratories and Abbott Laboratories
6. Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo
7. Zacks Releases Four Powerful Buy Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver
8. The Zacks Analyst Blog Highlights: UnitedHealth Group, Aetna, WellPoint, CIGNA and Wright Medical Group
9. Zacks Voice of the People highlights opportunities with Walgreen, Occidental Petroleum and Brown & Brown
10. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
11. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology:
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):